View Clinical Trial (Medical Research Study)
Continuing Care and Treatment for Patients With Cancer/AIDS/Skin Disease - NCT00001295-20892(Clinical Trial 111149)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Bethesda |
|
State:
|
|
MD |
| Zip Code: |
|
20892 |
| Conditions: |
|
Acquired Immunodeficiency Syndrome - Neoplasm - Skin Disease - HIV Infections |
| Purpose: |
|
This protocol is to provide continuing medical/surgical/radio-therapeutic care, treatment
and follow-up for NCI patients not currently entered on an active research protocol. No
investigational treatments will be administered on this protocol.
|
| Study summary: |
|
Background:
It may be in the interest of the CCR to continue to follow and treat certain subjects after
they have completed their treatment and participation on a research protocol.
Objective:
To provide continuing treatment and medical follow-up for CCR subjects who have completed
their treatment and participation on a research protocol and who are not currently entered
on or eligible for another active research protocol.
Eligibility:
Subjects who have been previously enrolled on and received treatment according to an
approved CCR research protocol. (clinical trial)
It is in the best interest of the subject and the CCR for the subject to continue to receive
standard care and follow-up at the NIH.
Design:
Medical/surgical/radiotherapeutic care, treatment and follow-up is provided for CCR subjects
who have completed their treatment and participation on a research protocol and who are not
currently entered on an active research protocol.
No investigational treatments will be administered. This protocol is not be used as a
platform to perform pilot studies of off-label uses for standard agents. |
| Criteria: |
|
- INCLUSION CRITERIA:
Subjects of any age who have been previously enrolled and treated on an approved CCR
research treatment protocol.
It is in the best interests of the subject and the CCR for the subject to continue to
receive treatment and follow-up at the NIH.
The subject or guardian signs the informed consent and agrees to the proposed treatment
regimen.
EXCLUSION CRITERIA:
Subjects who have not been previously treated on a CCR research treatment protocol.
Subjects who are receiving an investigational therapy. |
|
|
|
| Study is available at: |
|
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, MD 20892
United States
Primary Contact:
NCI Referral Office
Email: ncicssc@mail.nih.gov
Phone: 1-888-NCI-1937 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 21, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|